EW - Edwards Lifesciences Corp

QQQ $ 525.87 $ 4.67 (0.89 %)

DIA $ 447.30 $ -1.52 (-0.34 %)

SPY $ 607.78 $ 1.15 (0.19 %)

TLT $ 94.35 $ 0.14 (0.15 %)

GLD $ 242.95 $ 0.09 (0.04 %)

Previous Close

$ 71.53

Open

$ 72.71

Bid

$ 0.00 x 0

Ask

$ 71.58 x 100

Day's Range

-- - --

52 Week Range

$ 58.93 - $ 96.12

Volume

3,667,095

Average Volume

Market Cap

42.19B

Beta (5Y Monthly)

$ 1.15

PE Ratio (TTM)

$ 10.14

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2024	09-30-2024	10-Q
2	07-31-2024	06-30-2024	10-Q
3	04-29-2024	03-31-2024	10-Q
4	02-12-2024	12-31-2023	10-K
5	10-27-2023	09-30-2023	10-Q
6	07-28-2023	06-30-2023	10-Q
7	04-28-2023	03-31-2023	10-Q
8	02-13-2023	12-31-2022	10-K
9	10-28-2022	09-30-2022	10-Q
10	07-29-2022	06-30-2022	10-Q
11	04-28-2022	03-31-2022	10-Q
12	02-14-2022	12-31-2021	10-K
13	10-29-2021	09-30-2021	10-Q
14	07-30-2021	06-30-2021	10-Q
15	04-28-2021	03-31-2021	10-Q
16	02-12-2021	12-31-2020	10-K
17	10-26-2020	09-30-2020	10-Q
18	07-27-2020	06-30-2020	10-Q
19	04-28-2020	03-31-2020	10-Q
20	02-14-2020	12-31-2019	10-K
21	10-25-2019	09-30-2019	10-Q
22	07-26-2019	06-30-2019	10-Q
23	04-26-2019	03-31-2019	10-Q
24	02-15-2019	12-31-2018	10-K
25	10-26-2018	09-30-2018	10-Q
26	07-27-2018	06-30-2018	10-Q
27	04-27-2018	03-31-2018	10-Q
28	02-16-2018	12-31-2017	10-K
29	10-27-2017	09-30-2017	10-Q
30	07-28-2017	06-30-2017	10-Q
31	04-28-2017	03-31-2017	10-Q
32	02-17-2017	12-31-2016	10-K
33	10-28-2016	09-30-2016	10-Q
34	07-29-2016	06-30-2016	10-Q
35	04-29-2016	03-31-2016	10-Q
36	02-19-2016	12-31-2015	10-K
37	10-29-2015	09-30-2015	10-Q
38	07-29-2015	06-30-2015	10-Q
39	04-29-2015	03-31-2015	10-Q
40	02-20-2015	12-31-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Goldman Sachs Maintains Buy on Edwards Lif...
12/05/2024 17:34:31

Goldman Sachs analyst David Roman maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $81 t...

Truist Securities Reiterates Hold on Edwar...
12/05/2024 16:50:57

Truist Securities analyst Richard Newitter reiterates Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target...

Stifel Maintains Hold on Edwards Lifescien...
12/05/2024 16:06:17

Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $70 to $75.

RBC Capital Maintains Outperform on Edward...
12/05/2024 15:42:31

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from...

Canaccord Genuity Maintains Hold on Edward...
12/05/2024 12:30:26

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target ...

Edwards Lifesciences Outlines Vision For G...
12/04/2024 16:40:56

Edwards Lifesciences outlines 2025 growth strategy, emphasizing innovations in TAVR and TMTT therapies, with a projected sales ...

Edwards Lifesciences Expects 2025 Sales Of...
12/04/2024 11:07:15

2025 GuidanceSales$5.6 - $6.0 billion(8% - 10% constant currency growth)TAVR$4.1 - $4.4 billion(5% - 7% constant currency growt...

morgan-stanley-maintains-positive-medtech-outlook-despite-setbacks-in-2024-upgrades-intuitive-surgical-and-stryker-downgrades-nevro-and-glaukos

Morgan Stanley Maintains Positive MedTech ...
12/02/2024 19:29:58

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid comp...

The Analyst Verdict: Edwards Lifesciences ...
11/27/2024 18:01:10

RBC Capital Maintains Outperform on Edward...
11/27/2024 17:09:26

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from...

Edwards Lifesciences' SAPIEN 3 Ultra RESIL...
11/25/2024 08:41:27

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3...

why-is-boston-scientific-stock-trading-lower-on-wednesday

Why is Boston Scientific Stock Trading Low...
10/30/2024 19:08:50

Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, n...

Shares Of Boston Scientific See Volume; Co...
10/30/2024 15:38:33

https://event.choruscall.com/mediaframe/webcast.html?webcastid=MY6v7nFk

TRISCEND II Trial Shows Edwards EVOQUE Sys...
10/30/2024 15:03:43

Edwards Lifesciences Says EARLY TAVR Trial...
10/28/2024 15:15:50

Edwards Lifesciences Announces Results Fro...
10/28/2024 15:04:58

Edwards Lifesciences (NYSE:EW) today announced results from the EARLY TAVR Trial, the first randomized, controlled trial design...

tech-stocks-rally-as-investors-await-magnificent-7-earnings-dollar-eyes-fourth-straight-positive-week-whats-driving-markets-friday

Tech Stocks Rally As Investors Await Magni...
10/25/2024 17:19:53

Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earn...

Canaccord Genuity Maintains Hold on Edward...
10/25/2024 16:50:27

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target ...

JP Morgan Maintains Neutral on Edwards Lif...
10/25/2024 15:34:07

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $72...

Piper Sandler Maintains Neutral on Edwards...
10/25/2024 14:38:33

Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Neutral and lowers the price target from $...